Detrimental effects of adenosine signaling in sickle cell disease

Department of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
Nature medicine (Impact Factor: 27.36). 01/2011; 17(1):79-86. DOI: 10.1038/nm.2280
Source: PubMed


Hypoxia can act as an initial trigger to induce erythrocyte sickling and eventual end organ damage in sickle cell disease (SCD). Many factors and metabolites are altered in response to hypoxia and may contribute to the pathogenesis of the disease. Using metabolomic profiling, we found that the steady-state concentration of adenosine in the blood was elevated in a transgenic mouse model of SCD. Adenosine concentrations were similarly elevated in the blood of humans with SCD. Increased adenosine levels promoted sickling, hemolysis and damage to multiple tissues in SCD transgenic mice and promoted sickling of human erythrocytes. Using biochemical, genetic and pharmacological approaches, we showed that adenosine A(2B) receptor (A(2B)R)-mediated induction of 2,3-diphosphoglycerate, an erythrocyte-specific metabolite that decreases the oxygen binding affinity of hemoglobin, underlies the induction of erythrocyte sickling by excess adenosine both in cultured human red blood cells and in SCD transgenic mice. Thus, excessive adenosine signaling through the A(2B)R has a pathological role in SCD. These findings may provide new therapeutic possibilities for this disease.

Download full-text


Available from: Yingbo Dai,
  • Source
    • "The newly synthesized StAR is functional and plays a critical role in the transfer of cholesterol from the outer to the inner mitochondrial membrane, whereas mitochondrial import and processing to 30 kDa StAR protein terminate this action [140] [141] [142]. HbS polymerization is mediated by upstream activation of adenosine receptor A 2B R by hypoxia, and hemolysis of irreversibly sickled red blood cells increases adenosine bioavailability through conversion of ATP by ectonucleotidases CD39 and CD73, thus predisposing patients with SCD to sustained high levels of cAMP [143] [144]. From this point of view, steroidogenesis could be expected to be increased in these patients. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Sickle cell anemia is one of the best studied inherited diseases, and despite being caused by a single point mutation in the HBB gene, multiple pleiotropic effects of the abnormal hemoglobin S production range from vaso-occlusive crisis, stroke, and pulmonary hypertension to osteonecrosis and leg ulcers. Urogenital function is not spared, and although priapism is most frequently remembered, other related clinical manifestations have been described, such as nocturia, enuresis, increased frequence of lower urinary tract infections, urinary incontinence, hypogonadism, and testicular infarction. Studies on sickle cell vaso-occlusion and priapism using both in vitro and in vivo models have shed light on the pathogenesis of some of these events. The authors review what is known about the deleterious effects of sickling on the genitourinary tract and how the role of cyclic nucleotides signaling and protein kinases may help understand the pathophysiology underlying these manifestations and develop novel therapies in the setting of urogenital disorders in sickle cell disease.
    Anemia 06/2012; 2012:723520. DOI:10.1155/2012/723520
  • Source
    • "Increased adenosine levels promoted sickling, hemolysis and damage to multiple tissues in SCD transgenic mice and promoted sickling of human erythrocytes. (Zhang et al. 2011). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Signal transduction is defined as the transfer of a signal starting from a primary messenger with a ligand that binds to specific receptors on the cell membrane. The signal then reaches the effector molecule(s) through a cascade involving various protein kinases and/or protein phosphatases as well as other molecules such as adaptor proteins, anchoring proteins, amplifier proteins, etc. Although erythrocytes are nucleus-free cells, they use elements of cell signal pathways that help them to maintain membrane integrity, ion transport, and metabolism. Aging, some “stress” conditions, and various diseases also may generate cell signals into erythrocytes (Minetti и Low, 1997; Antonelou et al. 2010; Berzosa et al. 2011; Pantaleo et al. 2010). Molecules from both erythrocyte membranes and from cytosol may take part in signal transduction. Membrane components involved in signal transduction include receptors, heterotrimeric G-proteins, adaptor and anchoring proteins, and some proteins of the Ras-superfamily. The еrythrocyte intracellular signaling cascade is divided into protein kinases and phosphatases, second messengers and small GTPases, which could further be defined as cell surface and intracellular activities (Pasini et al. 2006). In general, the mechanisms of signal transduction in erythrocytes can be summarized in the following groups: 1) specific mechanisms triggering changes in the activity of erythrocyte enzymes, 2) specific mechanisms inducing changes in the activity of transport systems, 3) signal transduction related to membrane association/dissociation of cytoskeletal and integral proteins, 4) "stressful" conditions may induce activation of specific cellular signals into erythrocytes. Phosphorylation of the erythrocyte proteins by protein kinases and phosphatases is the key mechanism for controlling erythrocyte functions.
    Protein Kinases, edited by Gabriela Da Silva Xavier, 06/2012: chapter 12: pages 250-285; InTech., ISBN: ISBN 978-953-51-0640-1
  • Source
    • "The pathogenic potential of Adora2b in chronic inflammation is not restricted to the lung. For example, Adora2b signaling was recently revealed to be detrimental in sickle cell anemia, a context in which elevated levels of extracellular adenosine-Adora2b signaling promotes red blood cell sickling, contributing to the pathogenesis of this disease [44]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Anti-inflammatory signals play an essential role in constraining the magnitude of an inflammatory response. Extracellular adenosine is a critical tissue-protective factor, limiting the extent of inflammation. Given the potent anti-inflammatory effects of extracellular adenosine, we sought to investigate how extracellular adenosine regulates T cell activation and differentiation. Adenosine receptor activation by a pan adenosine-receptor agonist enhanced the abundance of murine regulatory T cells (Tregs), a cell type critical in constraining inflammation. Gene expression studies in both naïve CD4 T cells and Tregs revealed that these cells expressed multiple adenosine receptors. Based on recent studies implicating the Adora2b in endogenous anti-inflammatory responses during acute inflammation, we used a pharmacologic approach to specifically activate Adora2b. Indeed, these studies revealed robust enhancement of Treg differentiation in wild-type mice, but not in Adora2b(-/-) T cells. Finally, when we subjected Adora2b-deficient mice to endotoxin-induced pulmonary inflammation, we found that these mice experienced more severe inflammation, characterized by increased cell recruitment and increased fluid leakage into the airways. Notably, Adora2b-deficient mice failed to induce Tregs after endotoxin-induced inflammation and instead had an enhanced recruitment of pro-inflammatory effector T cells. In total, these data indicate that the Adora2b adenosine receptor serves a potent anti-inflammatory role, functioning at least in part through the enhancement of Tregs, to limit inflammation.
    PLoS ONE 02/2012; 7(2):e32416. DOI:10.1371/journal.pone.0032416 · 3.23 Impact Factor
Show more